Continuous Veno-Venous Hemodiafiltration or Hemofiltration: Impact on Calcium, Phosphate and Magnesium Concentrations
- 1 June 2002
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 25 (6) , 512-519
- https://doi.org/10.1177/039139880202500605
Abstract
Background and Objectives: Different techniques of continuous renal replacement therapy (CRRT) might have different effects on calcium, phosphate and magnesium concentrations. Accordingly, we tested whether continuous veno-venous hemodiafiltration (CVVHDF) or continuous venovenous hemofiltration (CVVH) would achieve better control of these electrolytes. Design: Retrospective controlled study Setting: Two tertiary Intensive Care Units Patients: Critically ill patients with acute renal failure (ARF) treated with CVVHDF (n=49) or CVVH (n=50) Interventions: Retrieval of daily morning ionized calcium, phosphate and magnesium before and after the initiation of CRRT for up to 2 weeks of treatment. Measurements and Results: Before treatment, both groups had a high incidence of abnormal ionized calcium concentrations (57.2% for CVVHDF vs 46.0% for CVVH; NS). After treatment, both groups showed a significant increase in serum calcium concentration over the first 48 h (p=0.041 vs p=0.0048) but hypercalcemia was more common during CVVHDF (15.3% vs 0.4%; p<0.0001). However, in both groups, hypocalcemia remained common (30.9% vs 36.7%; NS). Before treatment, abnormal serum phosphate concentrations were also common (65.1% for CVVHDF vs 78.1% for CVVH; NS). After treatment, both groups achieved a significant reduction of serum phosphate within 48 hours (p<0.0001 in both groups). There was no difference in the prevalence of abnormal phosphate levels during treatment (45.5% vs 42.4%; NS). Before treatment, both groups had a high incidence of abnormal magnesium concentrations (50.0% for CVVHDF vs 51.2% for CVVH; NS). During treatment, there was no significant change in serum magnesium concentrations during the first 48 hours or in the prevalence of abnormal magnesium concentrations (56.3% vs 63.4%; p=0.13). However CVVHDF was associated with a higher prevalence of hypomagnesemia (8.1% vs 0.4%; p<0.0001) and a lower incidence of hypermagnesemia (48.2% vs. 63.0%; p=0.0014). Conclusions: In critically ill patients with ARF, calcium, phosphate and magnesium were commonly abnormal and they were only partly corrected by CRRT. CVVH and CVVHDF had a different effect on serum magnesium concentrations.Keywords
This publication has 27 references indexed in Scilit:
- Epidemiology, management, and outcome of severe acute renal failure of critical illness in AustraliaCritical Care Medicine, 2001
- Management of severe acute renal failure in critically ill patients: an international survey in 345 centresNephrology Dialysis Transplantation, 2001
- A Prospective, Multicenter Study of the Epidemiology, Management, and Outcome of Severe Acute Renal Failure in a “Closed” ICU SystemAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Continuous haemofiltration in the intensive care unitCritical Care, 2000
- Continuous renal replacement therapies: an update.American Journal of Kidney Diseases, 1998
- Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failureAmerican Journal of Kidney Diseases, 1996
- Acute renal failure in the intensive care unit: adequacy of dialysis and the case for continuous therapiesNephrology Dialysis Transplantation, 1996
- Acute renal failure in intensive care units--Causes, outcome, and prognostic factors of hospital mortalityCritical Care Medicine, 1996
- Adequacy of dialysis: A critical analysisKidney International, 1992
- Determinants of Survival and Recovery in Acute Renal Failure Patients Dialyzed in Intensive-Care UnitsAmerican Journal of Nephrology, 1991